Global Gynecological Cancers Therapeutics Market 2022-2026Technavio has been monitoring the gynecological cancers therapeutics market and it is poised to grow by $ 14.22 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our…
Global BRAF Kinase Inhibitors Market 2022-2026Technavio has been monitoring the braf kinase inhibitors market and it is poised to grow by $ 1.19 billion during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the braf k…
Global Zika Virus Therapeutics Market 2022-2026Technavio has been monitoring the zika virus therapeutics market and it is poised to grow by $ 4.97 billion during 2022-2026, accelerating at a CAGR of 5.25% during the forecast period. Our report on the zika…
Global Probiotic Supplements Market In Canada 2022-2026Technavio has been monitoring the probiotic supplements market in Canada and it is poised to grow by $ 59.76 mn during 2022-2026, accelerating at a CAGR of 5.9% during the forecast period. Our report …
Global Primary Immunodeficiency Therapeutics Market 2022-2026Technavio has been monitoring the primary immunodeficiency therapeutics market and it is poised to grow by $ 3.13 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.…
Global Tetanus Toxoid Vaccine Market 2022-2026
Technavio has been monitoring the tetanus toxoid vaccine market and it is poised to grow by $ 1.17 bn during 2022-2026, accelerating at a CAGR of 4.3% during the forecast period. Our report on the tetanus tox…
Global Pharmacovigilance and Drug Safety Software Market 2022-2026Technavio has been monitoring the pharmacovigilance and drug safety software market and it is poised to grow by $ 72.74 mn during 2022-2026, accelerating at a CAGR of 7.11% during the forec…
Global Human Vaccine Market 2022-2026Technavio has been monitoring the human vaccine market and it is poised to grow by $ 20.37 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the human vaccine market provide…
Global Japanese Encephalitis Vaccines Market 2022-2026Technavio has been monitoring the Japanese encephalitis vaccines market and it is poised to grow by $ 58.27 mn during 2022-2026, accelerating at a CAGR of 5.98% during the forecast period. Our report o…
[ 170 + Pages Research Report ] Hypodermic Needles Market to surpass USD 5 billion by 2031 from USD 2.9 billion in 2021 at a CAGR of 5.4% in the coming years, i.e., 2021-2031.Product OverviewHypodermic needle is a hollow needle that is widely used with a …
[ 170 + Pages Research Report ] Genomic Biomarkers Market to surpass USD 109.94 billion by 2031 from USD 41.43 billion in 2021 at a CAGR of 13.4% in the coming years, i.e., 2021-31.Product OverviewGenomic biomarkers are cancer detection markers that can b…
Product OverviewA bio-based formulation that is developed to protects humans against infectious diseases caused by bacteria and viruses is known as the vaccine. Vaccines, also known as immunizations, take advantage of our immune system's innate capacity t…
[170+ pages Report] Molecular Modeling Market to surpass USD 17.3 billion by 2031 from USD 13 billion in 2021 at a CAGR of 13.8% in the coming years, i.e., 2021-31. Product OverviewThe technique of molecular modelling is used in medication development. It…
[ 170 + Pages Research Report ] Advanced (3D/4D) Visualization Systems Market to surpass USD 4.1 billion by 2031 from USD 2.4 billion in 2021 at a CAGR of 5.5% in the coming years, i.e., 2021-2031. Product OverviewAdvanced visualization techniques are emp…
The global molecular diagnostics market was valued at $9,160.61 million in 2020 and is projected to reach $23,905.56 million by 2030, registering a CAGR of 9.86% from 2021 to 2030.Molecular diagnosis is a process to identify a disease at the molecular lev…
Longevity and Anti-senescence Therapy Market By Therapy (Senolytic Drug Therapy, Gene Therapy, Immunotherapy), By Application (Cancer, Others), By End user (Hospital, Medical Service Institution): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global longevity and anti-senescence therapy market was valued at $25,087.3 million in 2020, and is projected to reach $44,234.8 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.Aging is marked by a progressive loss of physiological integ…
Transdermal Drug Delivery Systems Market By Type Of Delivery System (Passive, Active), By Application (Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global transdermal drug delivery systems market size was valued at $52,476.5 million in 2020, and is projected to reach $87,322.4 million by 2030, registering a CAGR of 4.9% from 2021 to 2030. Transdermal drug delivery systems are dosage forms that ar…
Surgical Microscopes Market By Application (Dentistry, Ent, Gynecology & Urology, Neurosurgery & Spine Surgery, Oncology, Ophthalmology, Plastic And Reconstructive Surgeries), By End-User (Hospitals, Outpatient Facilities), By Price Range (Low-Range, Mid-Range, Premium-Range), : Global Opportunity Analysis and Industry Forecast, 2020-2030
The surgical microscopes market size was valued at $612.79 million in 2020, and is estimated to reach $1399.09 million by 2030, growing at a CAGR of 8.6% from 2021 to 2030.Surgical microscope is a solution to present problem of complex and difficult surgi…
Pharmaceutical Glycerin Based Products Market By Drug Type (Dermatological, Opthalmic, Cough Remidies, Glycerine Rectal, Angina): Global Opportunity Analysis and Industry Forecast, 2020-2030
Pharmaceutical glycerin is an organic compound known as glycerol and glycerin and is majorly used as an excipient in the pharmaceutical industry. Glycerin exhibits various benefits in medical and pharmaceutical preparations, such as improving smoothness, …
Aneurysmal Subarachnoid Hemorrhage Drugs Market By Drug Class (Opioid Analgesic, Calcium Channel Blocker, Anticonvulsant, Stool Softener, Osmotic Agents/Diuretics, Other Drugs): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global aneurysmal subarachnoid hemorrhage drugs market was valued at $323.51 million in 2020, and is projected to reach $456.31 million by 2030, registering a CAGR of 3.6% from 2021 to 2030.Aneurysmal subarachnoid hemorrhage (aSAH) is a condition in w…